https://doi.org/10.1002/14651858.CD015391
Cochrane disclaims all liability and responsibility arising from any reliance placed on this supplementary material which has been supplied by the author(s). The above associated publication’s Author Licence will apply in respect of any supplemental materials published. How to cite the supplementary material is defined in the Cochrane policy.
Methods |
|
Participants |
Inclusion criteria
Exclusion criteria
|
Interventions |
Details of intervention
Treatment details of control group (e.g. type, dose, route of administration)
|
Outcomes |
Primary study outcomes
Relevant study outcomes planned
Secondary outcomes
|
Notes |
|
Methods |
|
Participants |
Inclusion criteria
Exclusion criteria
|
Interventions |
Details of intervention of relevant arms
Treatment details of control group (e.g. type, dose, route of administration)
|
Outcomes |
Primary study outcomes
|
Notes |
|
COVID-19: coronavirus disease 2019; SARS-CoV-2: Severe Acute Respiratory Syndrome Coronavirus 2; SSRIs: selective serotonin reuptake inhibitors